These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27188806)

  • 1. Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study.
    Heng JS; Wormald R; Khaw PT
    BMJ Open; 2016 May; 6(5):e010429. PubMed ID: 27188806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice.
    Alagöz N; Tellioglu A; Bektasoglu DL; Yasar T; Basgil Pasaoglu I; Altan AC; Solmaz B; Basarır B
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):747-753. PubMed ID: 33326338
    [No Abstract]   [Full Text] [Related]  

  • 3. Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.
    Trese MGJ; Lewis AW; Blachley TS; Stein JD; Moroi SE
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):591-597. PubMed ID: 28854348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year risk of progression of ocular hypertension to primary open angle glaucoma. A population-based study.
    Thomas R; Parikh R; George R; Kumar RS; Muliyil J
    Indian J Ophthalmol; 2003 Dec; 51(4):329-33. PubMed ID: 14750621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing Trends of Topical Glaucoma Medications in Australia From 2001 to 2017.
    Perera N; Pinnuck BC; Jamieson MPH; Ling D; Williams M; Chen O
    J Glaucoma; 2020 Mar; 29(3):175-183. PubMed ID: 31790066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
    Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
    Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
    Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.
    Fadini GP; Pagano C; Baesso I; Kotsafti O; Doro D; de Kreutzenberg SV; Avogaro A; Agostini C; Dorigo MT
    Acta Ophthalmol; 2010 Feb; 88(1):135-41. PubMed ID: 19549102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
    J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucoma prescribing trends in England 2000 to 2012.
    Connor AJ; Fraser SG
    Eye (Lond); 2014 Jul; 28(7):863-9. PubMed ID: 24858531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA.
    Vié AL; Kodjikian L; Malclès A; Agard E; Voirin N; El Chehab H; Nguyen AM; Dot C
    Retina; 2017 Jan; 37(1):173-178. PubMed ID: 27465569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.
    Chen YY; Wang TH; Liu C; Wu KY; Chiu SL; Simonyi S; Lu DW
    BMC Ophthalmol; 2016 Sep; 16(1):162. PubMed ID: 27633513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension.
    Fuchsjäger-Mayrl G; Wally B; Rainer G; Buehl W; Aggermann T; Kolodjaschna J; Weigert G; Polska E; Eichler HG; Vass C; Schmetterer L
    Br J Ophthalmol; 2005 Oct; 89(10):1293-7. PubMed ID: 16170119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular response analyser to assess hysteresis and corneal resistance factor in low tension, open angle glaucoma and ocular hypertension.
    Shah S; Laiquzzaman M; Mantry S; Cunliffe I
    Clin Exp Ophthalmol; 2008 Aug; 36(6):508-13. PubMed ID: 18954311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein filling defects of the optic nerve head in normal tension glaucoma, primary open-angle glaucoma, ocular hypertension and healthy controls.
    Plange N; Kaup M; Huber K; Remky A; Arend O
    Ophthalmic Physiol Opt; 2006 Jan; 26(1):26-32. PubMed ID: 16390479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy compliance in patients with ocular hypertension or primary open-angle glaucoma.
    Traverso CE; Walt JG; Stern LS; Dolgitser M
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):77-82. PubMed ID: 19232009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma.
    Landers J; Goldberg I; Graham SL
    Clin Exp Ophthalmol; 2002 Aug; 30(4):242-7. PubMed ID: 12121361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health- and vision-related quality of life in patients with ocular hypertension or primary open-angle glaucoma.
    Wolfram C; Lorenz K; Breitscheidel L; Verboven Y; Pfeiffer N
    Ophthalmologica; 2013; 229(4):227-34. PubMed ID: 23614930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.